How to Manage Loose Skin Concerns After Weight Loss
The medicines help patients eat less, improve glucose control and may cut heart attack and stroke risk, doctors said.
- A new study from the National Taiwan University Hospital found patients using GLP-1 medications had a 41 percent lower overall risk of developing 13 obesity-related cancers compared to those relying on lifestyle interventions alone.
- Originally developed to treat type 2 diabetes, GLP-1 receptor agonists mimic natural hormones to regulate appetite and blood sugar levels, helping patients feel fuller while slowing digestion.
- Researchers analyzed U.S. TriNetX electronic health records from more than 160,000 patients between 2014 and 2025, using propensity score matching to compare treatments over two years.
- Hsu Heng-cheng of NTUH's Department of Obstetrics and Gynecology reported the greatest risk reductions occurred in endometrial and colorectal cancers, though he cautioned findings do not establish a new approved indication.
- Published in the August issue of Annals of Oncology, the research addresses limited evidence on whether these drugs—often called "skinny jabs"—reduce cancer risk in obese patients without diabetes.
30 Articles
30 Articles
The Times of Northwest Indiana
Don’t curtail access to weight-loss drugs
Last November, a patient of mine — 19 years old and established in our primary care clinic in Massachusetts — came in for her annual physical. She’d done everything we’d asked for her chronic obesity. She’d traded the bus for…
Focus Taiwan
Taipei TimesNTUH GLP-1 drug study points to drop in obesity-linked cancer risk
Taipei, Aug. 6 (CNA) Weight-loss injections based on GLP-1 receptor agonists were associated with a 41 percent lower risk of developing 13 obesity-related cancers than weight loss achieved through diet and exercise alone, according to a National Taiwan University Hospital (NTUH) study.
The GLP-1 Revolution: The weight-loss drugs changing lives
“Food just doesn’t occupy my mind anymore.” It’s a phrase doctors who prescribe GLP-1 medicines hear time and again. For many people living with obesity, constant hunger isn’t simply about a lack of willpower—it’s driven by powerful biological signals that tell the brain to eat, even when the body has enough energy. That’s why the latest generation of weight-loss medicines has generated so much… Source
Can the Latest Diet Drugs Help You Start a Family?
Struggling to grow your family can feel like an uphill battle, especially when you’re sorting through endless health advice. And if you’re taking or considering GLP-1 medications like Ozempic or Wegovy and dreaming of a baby too, you probably have big questions. The latest data is finally shedding light on how these popular drugs impact fertility for both men and women—and the answers might surprise you. Scroll through social media and you’ll …
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
